27.5 C
New York

Tag: Novo Nordisk A/S

WASHINGTON — One year ago this week, President Donald Trump seized unprecedented control of the nation’s capital. Source link
Novo Nordisk CEO defended the company's decision to sue rival Eli Lilly over its weight-loss drug advertising. Source link

Here are 4 forces that drove a tough week for stocks

It was a tough week for stocks, as investors navigated everything from escalating tensions in the Middle East to key tech earnings reports to...

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

Michael Siluk | UCG | Universal Images Group | Getty ImagesLosing weight with GLP-1 drugs is only half the battle. Keeping it off long...

White House adds generic drugs to direct-to-consumer TrumpRx site

US President Donald Trump speaks to introduce the new TrumpRx website in the South Court Auditorium of the White House in Washington, DC, on...

Amazon launches GLP-1 weight loss program, promising ‘fast, convenient’ access

Amazon GLP-1 treatmentSource: Amazon Inc. Amazon is pushing deeper into the booming weight loss market, unveiling Tuesday a new program that aims to simplify...

Novo Nordisk partners with OpenAI as AI drug discovery hopes mount 

Novo Nordisk is partnering with OpenAI to "bring new and better treatment options to patients faster," the Danish drugmaker said Tuesday. The partnership will enable...

Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment

After years of trying to lose weight "the right way," Jane Zuckerman realized that "putting in the work just wasn't enough." Zuckerman, a 32-year-old data...

Stocks soar on hopes of Iran war resolution — plus, Lilly takes a big swing in sleep disorders

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour...

Eli Lilly shares slide after a bearish Wall Street analyst call — here’s our view

Eli Lilly shares are down 6% Tuesday and on pace for their worst day since February after an HSBC downgrade. The crux of HSBC's...

Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026.Tom Little | ReutersNovo...

Hims & Hers pulls copycat weight-loss pill after threats of legal action

Piotr Swat | Lightrocket | Getty ImagesHims & Hers on Saturday said that it will pull its copycat weight-loss pill off the market after...

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026.George Frey | Bloomberg | Getty ImagesThe future...

Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here...

Recent articles

spot_img